Arpita Joshi

Dr. Arpita Joshi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Clinical and Translational Science
Verified
Journal Article
Open access
DUDeepak R. Unni
Deepak R. Unni
SMSierra A. T. Moxon
Sierra A. T. Moxon
MBMichael Bada
Michael Bada
MBMatthew Brush
Matthew Brush
RBRichard Bruskiewich
Richard Bruskiewich
VDVenkata R Duvvuri
Venkata R Duvvuri
Within clinical, biomedical, and translational science, an increasing number of projects are adopting graphs for knowledge representation. Graph‐based data models elucidate the interconnectedness among core biomedical concepts, enable data structures to be easily updated, and support intuitive queries, visualizations, and inference algorithms. However, knowledge discovery across these “knowledge graphs” (KGs) has remained difficult. Data set heterogeneity and complexity; the proliferation of ad hoc data formats; poor compliance with guidelines on findability, accessibility, interoperability, and reusability; and, in particular, the lack of a universally accepted, open‐access model for standardization across biomedical KGs has left the task of reconciling data sources to downstream consumers. Biolink Model is an open‐source data model that can be used to formalize the relationships between data structures in translational science. It incorporates object‐oriented classification and graph‐oriented features. The core of the model is a set of hierarchical, interconnected classes (or categories) and relationships between them (or predicates) representing biomedical entities such as gene, disease, chemical, anatomic structure, and phenotype. The model provides class and edge attributes and associations that guide how entities should relate to one another. Here, we highlight the need for a standardized data model for KGs, describe Biolink Model, and compare it with other models. We demonstrate the utility of Biolink Model in various initiatives, including the Biomedical Data Translator Consortium and the Monarch Initiative, and show how it has supported easier integration and interoperability of biomedical KGs, bringing together knowledge from multiple sources and helping to realize the goals of translational science.

19 September 2024 in eneuro
Verified
Journal Article
Open access
PDF file
AJArpita Joshi
Arpita Joshi
Federico Manuel GiorgiFederico Manuel Giorgi
Federico Manuel Giorgi
PSPietro Sanna
Pietro Sanna
Advances in single-cell technologies have led to the discovery and characterization of new brain cell types, which in turn lead to a better understanding of the pathogenesis of Alzheimer's disease (AD). Here, we present a detailed analysis of single-nucleus (sn)RNA-seq data for three stages of AD from middle temporal gyrus and compare it with snRNA-seq data from the prefrontal cortices from individuals with alcohol use disorder (AUD). We observed a significant decrease in both inhibitory and excitatory neurons, in general agreement with previous reports. We observed several cell-type–specific gene expressions and pathway dysregulations that delineate AD stages. Endothelial and vascular leptomeningeal cells showed the greatest degree of gene expression changes. Cell-type–specific evidence of neurodegeneration was seen in multiple neuronal cell types particularly in somatostatin and Layer 5 extratelencephalic neurons, among others. Evidence of inflammatory responses was seen in non-neuronal cells, particularly in intermediate and advanced AD. We observed common perturbations in AD and AUD, particularly in pathways, like transcription, translation, apoptosis, autophagy, calcium signaling, neuroinflammation, and phosphorylation, that imply shared transcriptional pathogenic mechanisms and support the role of excessive alcohol intake in AD progression. Major AUD gene markers form and perturb a network of genes significantly associated with intermediate and advanced AD. Master regulator analysis from AUD gene markers revealed significant correlation with advanced AD of transcription factors that have implications in intellectual disability, neuroinflammation, and other neurodegenerative conditions, further suggesting a shared nexus of transcriptional changes between AD and AUD.

15 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GQGuangrong Qin
Guangrong Qin
KNKamileh Narsinh
Kamileh Narsinh
QWQi Wei
Qi Wei
JRJared C Roach
Jared C Roach
AJArpita Joshi
Arpita Joshi
GGGwênlyn Glusman
Gwênlyn Glusman
As large clinical and multiomics datasets and knowledge resources accumulate, they need to be transformed into computable and actionable information to support automated reasoning. These datasets range from laboratory experiment results to electronic health records (EHRs). Barriers to accessibility and sharing of such datasets include diversity of content, size and privacy. Effective transformation of data into information requires harmonization of stakeholder goals, implementation, enforcement of standards regarding quality and completeness, and availability of resources for maintenance and updates. Systems such as the Biomedical Data Translator leverage knowledge graphs (KGs), structured and machine learning readable knowledge representation, to encode knowledge extracted through inference. We focus here on the transformation of data from multiomics datasets and EHRs into compact knowledge, represented in a KG data structure. We demonstrate this data transformation in the context of the Translator ecosystem, including clinical trials, drug approvals, cancer, wellness, and EHR data. These transformations preserve individual privacy. We provide access to the five resulting KGs through the Translator framework. We show examples of biomedical research questions supported by our KGs, and discuss issues arising from extracting biomedical knowledge from multiomics data.

19 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
AJArpita Joshi
Arpita Joshi
NHNurit Haspel
Nurit Haspel
EGEduardo González
Eduardo González
Datasets representing the conformational landscapes of protein structures are high dimensional and hence present computational challenges. Efficient and effective dimensionality reduction of these datasets is therefore paramount to our ability to analyze the conformational landscapes of proteins and extract important information regarding protein folding, conformational changes and binding. Representing the structures with fewer attributes that capture the most variance of the data, makes for quicker and precise analysis of these structures. In this work we make use of dimensionality reduction methods for reducing the number of instances and for feature reduction. The reduced dataset that is obtained is then subjected to topological and quantitative analysis. In this step we perform hierarchical clustering to obtain different sets of conformation clusters that may correspond to intermediate structures. The structures represented by these conformations are then analyzed by studying their high dimension topological properties to identify truly distinct conformations and holes in the conformational space that may represent high energy barriers. Our results show that the clusters closely follow known experimental results about intermediate structures, as well as binding and folding events.

29 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AJArpita Joshi
Arpita Joshi
PSPietro Paolo Sanna
Pietro Paolo Sanna
Chronic smoking worsens alcohol-related brain injury and impairs neurocognitive recovery, yet the cell-type-specific molecular interactions between alcohol use disorder (AUD) and smoking in the human brain remain largely unexplored. We analyzed single-nucleus RNA-seq from the prefrontal cortex of 73 individuals (614,932 nuclei, 24 cell types), comparing AUD versus controls, smoking versus controls, and combined AUD+smoking versus controls. In excitatory neurons, neuroinflammatory, complement, GPCR, kinase, proteostatic, and extracellular-matrix pathways confined to one or two subtypes in either condition alone expanded across nearly all subtypes when AUD and smoking co-occurred. Inhibitory neurons showed a parallel but distinct expansion, additionally recruiting translational regulation, RNA splicing, and deubiquitination pathways. Smoking alone produced widespread repression of bioenergetic, proteostatic, and synaptic pathways in excitatory neurons, whereas AUD produced mixed pathway activation and repression in excitatory neurons and broad inflammatory activation in inhibitory neurons. In the combined condition, microglia exhibited paradoxical repression of phagocytosis, TYROBP signaling, and translational machinery, consistent with an exhaustion-like state, accompanied by an apparently compensatory shift in inflammatory signaling toward astrocytes, oligodendrocyte precursor cells, and oligodendrocytes, which showed coordinated inflammatory activation. Vascular cells showed an endothelial–VLMC dichotomy, with endothelial repression of RNA processing and proteostasis contrasting with perivascular activation. Our analysis identifies bioenergetic and proteostatic stress as the predominant signature of smoking, whereas immune and metabolic activation characterize AUD. In AUD+Smoking, these alterations extend across more neuronal subtypes and include neuroinflammation, complement activation, altered signaling, proteostatic stress, and post-transcriptional remodeling associated with greater cortical dysfunction in co-occurring AUD and smoking.

31 May 2022 in Journal of Human, Earth, and Future
Verified
Journal Article
Closed access
PDF file
AJArpita Joshi
Arpita Joshi
NHNurit Haspel
Nurit Haspel
EGEduardo González
Eduardo González
Datasets representing the conformational landscapes of protein structures are high-dimensional and hence present computational challenges. Efficient and effective dimensionality reduction of these datasets is therefore paramount to our ability to analyze the conformational landscapes of proteins and extract important information regarding protein folding, conformational changes, and binding. Representing the structures with fewer attributes that capture the most variance in the data makes for a quicker and more precise analysis of these structures. In this study, we make use of dimensionality reduction methods for reducing the number of instances and for feature reduction. The reduced dataset that is obtained is then subjected to topological and quantitative analysis. In this step, we perform hierarchical clustering to obtain different sets of conformation clusters that may correspond to intermediate structures. The structures represented by these conformations are then analyzed by studying their high-dimensional topological properties to identify truly distinct conformations and holes in the conformational space that may represent high energy barriers. Our results show that the clusters closely follow known experimental results about intermediate structures as well as binding and folding events. Doi: 10.28991/HEF-SP2022-01-01 Full Text: PDF